Adma Biologics (ADMA) Depreciation and Depletion (2018 - 2020)
Adma Biologics (ADMA) posted Depreciation and Depletion of $900000.0 for Q3 2020, up 50.0% on a QoQ basis from $600000.0 in Q1 2020, and up 50.0% year-over-year from $600000.0 in Q4 2019.
Adma Biologics (ADMA) Depreciation and Depletion (2018 - 2020) Analysis & Trends
Adma Biologics' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $900000.0 for Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 900,000.00 |
| Sep 30, 2020 | 900,000.00 |
| Mar 31, 2020 | 600,000.00 |
| Mar 31, 2020 | 600,000.00 |
| Sep 30, 2019 | 600,000.00 |
| Sep 30, 2019 | 600,000.00 |
| Jun 30, 2019 | 600,000.00 |
| Jun 30, 2019 | 600,000.00 |
| Mar 31, 2019 | 600,000.00 |
| Mar 31, 2019 | 600,000.00 |
| Sep 30, 2018 | 600,000.00 |
| Sep 30, 2018 | 600,000.00 |
| Jun 30, 2018 | 600,000.00 |
| Jun 30, 2018 | 600,000.00 |
| Mar 31, 2018 | 600,000.00 |
| Mar 31, 2018 | 600,000.00 |